Insulet
PODD
#1316
Rank
S$21.47 B
Marketcap
S$305.03
Share price
-0.12%
Change (1 day)
-3.23%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: S$21.47 Billion

As of March 2026 Insulet has a market cap of S$21.47 Billion. This makes Insulet the world's 1316th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$21.47 B-17.68%
2025S$26.08 B3.19%
2024S$25.27 B26.33%
2023S$20.01 B-26.99%
2022S$27.40 B10.48%
2021S$24.80 B11.27%
2020S$22.29 B54.1%
2019S$14.46 B125.58%
2018S$6.41 B19.44%
2017S$5.37 B71.47%
2016S$3.13 B2.81%
2015S$3.04 B-11.1%
2014S$3.42 B32.85%
2013S$2.57 B105.53%
2012S$1.25 B8.58%
2011S$1.15 B27.39%
2010S$0.90 B19.87%
2009S$0.75 B167.46%
2008S$0.28 B-67.32%
2007S$0.86 B

End of Day market cap according to different sources

On Mar 9th, 2026 the market cap of Insulet was reported to be:

S$21.49 Billion
by Nasdaq info icon info icon
S$21.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$747.64 B 3,381.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$245.37 B 1,042.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$147.93 B 588.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$1.145 T 5,232.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S$1.91 B-91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$4.23 B-80.29%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$33.83 B 57.57%๐Ÿ‡บ๐Ÿ‡ธ USA